Nickson Philip
Chief Business & Legal Officer
Nickson Philip has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Apr 10, 2026.
On the most recent filing, Nickson Philip is listed as Chief Business & Legal Officer at Monte Rosa Therapeutics, Inc. Inside the rolling window, Nickson Philip reported no open-market purchases and 2 open-market sales totaling $151K in GLUE. The largest disclosed transaction in the window is a sale of 5,845 GLUE shares on Apr 9, 2026, worth $103K.
Companies traded
Other insiders at GLUE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$151K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Nickson Philip made?
Nickson Philip has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Nickson Philip trade?
Nickson Philip has filed SEC Form 4 disclosures for 1 company, including GLUE.
When was Nickson Philip's most recent SEC Form 4 filing?
Nickson Philip's most recent SEC Form 4 filing on Tracefour is dated Apr 10, 2026.
What is Nickson Philip's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Nickson Philip is listed as Chief Business & Legal Officer.
What is Nickson Philip's total buy and sell value in the current window?
Inside the rolling retention window, Nickson Philip bought $0 and sold $151K based on SEC Form 4 filings.
What was Nickson Philip's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,845 GLUE shares on 2026-04-09, worth $103K, per SEC Form 4 filings.